Evidence map›Paper›PMID 38498424›Full record

SynthesisPloS one2024

A meta-analysis into the mediatory effects of family planning utilization on complications of pregnancy in women of reproductive age.

Shayesteh Jahanfar, Olivia Maurer, Amy Lapidow, Anjali Rajkumari Oberoi, Meredith Steinfeldt, Moazzam Ali

Open access · goldAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Shayesteh JahanfarDepartment of Public Health and Community Medicine, Director of Tufts University, Boston, MA, United States of America.
Olivia MaurerSchool of Medicine, Tufts University School of Medicine, Boston, MA, United States of America.ORCID 0009-0006-0132-0454
Amy LapidowDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States of America.
Anjali Rajkumari OberoiAffiliate of Cochrane US, Tufts University School of Medicine, Boston, MA, United States of America.
Meredith SteinfeldtDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States of America.
Moazzam AliWHO Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.ORCID 0000-0001-6949-8976
Tufts University · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundDespite conflicting findings in the current literature regarding the correlation between contraceptives and maternal health consequences, statistical analyses indicate that family planning may decrease the occurrence of such outcomes. Consequently, it is crucial to assess the capability of family planning to mitigate adverse maternal health outcomes.

objectivesThis review investigates the effects of modern contraceptive use on maternal health. SEARCH

methodsThis systematic review is registered on Prospero (CRD42022332783). We searched numerous databases with an upper date limit of February 2022 and no geographical boundaries. SELECTION CRITERIA: We included observational studies, including cross-sectional, cohort, case-control studies, and non-RCT with a comparison group. We excluded systematic reviews, scoping reviews, narrative reviews, and meta-analyses from the body of this review. MAIN

resultsThe review included nineteen studies, with five studies reporting a reduction in maternal mortality linked to increased access to family planning resources and contraceptive use. Another three studies examined the impact of contraception on the risk of preeclampsia and our analysis found that preeclampsia risk was lower by approximately 6% among contraceptive users (95% CI 0.82-1.13) compared to non-users. Two studies assessed the effect of hormonal contraceptives on postpartum glucose tolerance and found that low-androgen contraception was associated with a reduced risk of gestational diabetes (OR 0.84, 95% CI 0.58-1.22), while DMPA injection was possibly linked to a higher risk of falling glucose status postpartum (OR 1.42, 95% CI 0.85-2.36). Two studies evaluated high-risk pregnancies and births in contraceptive users versus non-users, with the risk ratio being 30% lower among contraceptive users of any form (95% CI 0.61, 0.80). None of these results were statistically significant except the latter. In terms of adverse maternal health outcomes, certain contraceptives were found to be associated with ectopic pregnancy and pregnancy-related venous thromboembolism through additional analysis.

Indexed as

Family Planning ServicesPre-EclampsiaContraceptionContraceptives, Oral, HormonalCross-Sectional StudiesFemaleGlucoseHumansPregnancyContraceptives, Oral, HormonalGlucose

Identifiers

PMID38498424
PMCPMC10947693
OpenAlexW4392928116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.